What is a stock summary page? Click here for an overview.
Business Description
Embla Medical hf
ISIN : IS0000000040
Compare
Compare
Traded in other countries / regions
EMBLA.Denmark0FIW.UKOSSFF.USA IPO Date
2016-03-29Description
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 3.01 | |||||
| Interest Coverage | 4.56 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.86 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.5 | |||||
| 3-Year EBITDA Growth Rate | 7.2 | |||||
| 3-Year EPS without NRI Growth Rate | 4.2 | |||||
| 3-Year FCF Growth Rate | 3.7 | |||||
| 3-Year Book Growth Rate | 10.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.21 | |||||
| 9-Day RSI | 2.35 | |||||
| 14-Day RSI | 5.82 | |||||
| 3-1 Month Momentum % | -13.92 | |||||
| 6-1 Month Momentum % | 1.34 | |||||
| 12-1 Month Momentum % | 2.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.41 | |||||
| Days Inventory | 162.49 | |||||
| Days Sales Outstanding | 54.68 | |||||
| Days Payable | 36.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -3.84 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.56 | |||||
| Operating Margin % | 13.2 | |||||
| Net Margin % | 7.98 | |||||
| FCF Margin % | 9.01 | |||||
| ROE % | 9.13 | |||||
| ROA % | 4.49 | |||||
| ROIC % | 6.17 | |||||
| 3-Year ROIIC % | 5.25 | |||||
| ROC (Joel Greenblatt) % | 32.31 | |||||
| ROCE % | 8.83 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.67 | |||||
| PE Ratio without NRI | 23.67 | |||||
| Shiller PE Ratio | 24.03 | |||||
| Price-to-Owner-Earnings | 18.03 | |||||
| PEG Ratio | 2.78 | |||||
| PS Ratio | 1.89 | |||||
| PB Ratio | 2.03 | |||||
| Price-to-Free-Cash-Flow | 20.77 | |||||
| Price-to-Operating-Cash-Flow | 13.83 | |||||
| EV-to-EBIT | 17.56 | |||||
| EV-to-EBITDA | 11.82 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-FCF | 26.25 | |||||
| Price-to-GF-Value | 0.72 | |||||
| Price-to-Projected-FCF | 1.21 | |||||
| Price-to-DCF (Earnings Based) | 1.57 | |||||
| Price-to-DCF (FCF Based) | 1.37 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.62 | |||||
| Earnings Yield (Greenblatt) % | 5.69 | |||||
| FCF Yield % | 4.75 | |||||
| Forward Rate of Return (Yacktman) % | 12.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Embla Medical hf Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 5,909.037 | ||
| EPS (TTM) (kr) | 1.112 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.6 | ||
| Volatility % | 28.66 | ||
| 14-Day RSI | 5.82 | ||
| 14-Day ATR (kr) | 0.103669 | ||
| 20-Day SMA (kr) | 28.87 | ||
| 12-1 Month Momentum % | 2.36 | ||
| 52-Week Range (kr) | 28.1 - 36.3 | ||
| Shares Outstanding (Mil) | 426.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Embla Medical hf Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Embla Medical hf Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Embla Medical hf Frequently Asked Questions
What is Embla Medical hf(LTS:0FIW)'s stock price today?
The current price of LTS:0FIW is kr28.10. The 52 week high of LTS:0FIW is kr36.30 and 52 week low is kr28.10.
When is next earnings date of Embla Medical hf(LTS:0FIW)?
The next earnings date of Embla Medical hf(LTS:0FIW) is 2025-04-29.
Does Embla Medical hf(LTS:0FIW) pay dividends? If so, how much?
Embla Medical hf(LTS:0FIW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers